 As small-molecule, synthetic, DNA minor groove binding alkylating agents, duocarmycins are suitable to target solid tumors.They bind to the minor groove of DNA and alkylate the nucleobase adenine at the N3 position.The irreversible alkylation of DNA disrupts the nucleic acid architecture, which eventually leads to tumor cell death.